Lowering prescription drug prices is a major priority for the American people. So why is Speaker Pelosi putting a partisan drug plan, which she knows won’t become law, on theHouse Floor tomorrow? Her bill is unconstitutional. It’s dead on arrival in the Senate. President Trump has vowed to veto it.

But there’s a better way. After months of work, Republican committee leaders recently introduced H.R. 19, The Lower Costs, More Cures Act. Every single provision in H.R. 19 has demonstrated bipartisan support.

H.R. 19 could become law. It could be on the President’s desk tomorrow. Senior citizens could be paying less for prescription drug prices this very month, if only Speaker Pelosi would abandon her extreme partisan plans.

H.R. 3, Pelosi’s partisan drug plan:

  • Undermines access to lifesaving medicines. Under Pelosi’s partisan plan, the Congressional Budget Office (CBO) estimates 15 fewer cures would be developed. The Council of Economic Advisers (CEA) estimates it’d be more like 100 fewer cures.
  • Uses the weight of the federal government to threaten manufacturers with a 95 percent tax on revenue if they don’t comply with bureaucratic demands. That’s not negotiation, that’s coercion.
  • Jeopardizes months of bipartisan work to cap senior citizens’ out-of-pocket costs for prescription drug spending by opting for a partisan plan to appease progressives.
  • Is unconstitutional! Analysis by the Congressional Research Service (CRS) concluded Pelosi’s partisan plan could violate both the Fifth Amendment’s Takings Clause, as well as the Eight Amendment’s Excessive Fines Clause.
  • Will not be signed by President Trump.

H.R. 19, a bipartisan alternative:

  • Encourages innovation of groundbreaking new cures, promotes more low-cost options for patients, and curbs the gaming of the system by drug companies.
  • For the first time ever, places a cap on seniors’ out-of-pocket drug costs and allow seniors to manage their annual out-of-pocket spending.
  • Makes insulin more affordable.
  • Increases transparency and removes uncertainty at the pharmacy counter.
  • Cuts the cost of drug administration, including cancer treatment, for Medicare beneficiaries by as much as half.
  • Stops subsidizing other developed counties health care through stronger trade agreement with real enforcement mechanisms.
  • Could actually become law!

Additional Resources

Highlights from President Trump’s Statement of Administration Policy (veto threat):

  • “The Administration opposes passage of H.R. 3, which contains several provisions that would harm seniors and all who need lifesaving medicines.”
  • “In its current form, H.R. 3 would likely undermine access to lifesaving medicines.”
  • “This bill would also compromise the health of Americans by dramatically reducing the incentive to bring innovative therapeutics to market.”
  • “More importantly, the effects of these cost increases on individuals and their families will be significant, personal, and long-lasting.”
  • “Additionally, H.R. 19, the Lower Costs, More Cures Act . . . is also a far better approach to lowering drug prices and discovering life-saving cures than H.R. 3.”
  • “If H.R. 3 were presented to the President in its current form, he would veto the bill.”

To view the White House’s Statement of Administration Policy (veto threat) on H.R. 3, please click here or on the image above.

Highlights from Republican leaders’ letter to Speaker Pelosi requesting a vote on H.R. 19:

  • “The American people want action to lower the cost of prescription drugs. They do not want partisan bickering and messaging bills that go nowhere.”
  • “At no time did House Democrat leadership ever reach out to House Republicans to try and work together on this legislation. As a result, the legislation does not represent bipartisan input and has no chance of becoming law.”
  • “While the progressive wing of your caucus may be satisfied with a vote only on a partisan price control bill, all Members of the House deserve the opportunity to vote on comprehensive, bipartisan legislation that will reduce drug prices and create more cures.”

To view House GOP leaders’ letter to Speaker Pelosi urging her to allow a vote on H.R. 19, click here.